Related Experiment Video
Updated: Feb 26, 2026
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Uptake in the pancreatic uncinate process on the 111In-octreotide scintigraphy: How to distinguish physiological from
Amel Ait Boudaoud1, Bruno Verges, Jean M Petit
1aEndocrinology and Metabolic Disease Department, Hospital Européen Georges Pompidou bNuclear Medicine Department, Centre Georges François Leclerc cLE2I UMR 6306, CNRS, Arts and Crafts dINSERM CRI866, University of Bourgogne Franche-Comté, Dijon, France eNuclear Medicine Department, Center Antoine-Lacassagne, Nice, University of the Cote d'Azur fHospital Européen Georges Pompidou 20 Rue le Blanc gUniversity of Medecine Paris V Descartes 15 Rue de l'Ecole de Medecine, Paris, France.
Background:
The aim of this study was to assess the relevance of physiological In-octreotide uptake in the head of pancreas and to establish its imaging features in comparison with pathological uptake in patients with neuroendocrine tumors (NET).
Patients And Methods:
We retrospectively reviewed all patients that underwent In-octreotide single-photon emission tomography (SPECT) scintigraphy in our institution. Only patients with an isolated uptake in the head of the pancreas were included. In-octreotidescintigraphy consisted in planar whole-body and abdominal SPECT/computed tomography (CT) images acquired at 6 and 30 h' postinjection. Different imaging features of the pancreatic focalized uptake were assessed: its precise location on the pancreas head, shape, intensity [visually and quantitatively by calculating the pancreatic to hepatic uptake ratio (L/H ratio)] and intensity changes.
Results:
Thirteen patients out of 230 were included. Among them, a pancreatic NET was confirmed in five patients. On In-octreotide SPECT/CT, two of these had uptake located in the uncinate process, and three had uptake focused in the right lateral borders or in the whole head. SPECT images demonstrated high uptake (L/H ratio >2) in four patients out of five. In the eight remaining patients, pancreatic NET was ruled out. For all of these physiological cases, SPECT/CT acquisitions revealed that the uptake was both located in the uncinate process and with an L/H ratio below 2.
Conclusion:
The simple criteria of localization and uptake quantification can help to discriminate between a possible physiological uptake in the uncinate process of the pancreatic head and a pathological uptake induced by a NET.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...